JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $46 | -99.9% | 25,000 | +25.0% | 0.00% | 0.0% |
| Q3 2022 | $47,000 | -23.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $61,000 | -55.1% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $136,000 | -18.6% | 20,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $167,000 | +125.7% | 20,000 | +100.0% | 0.00% | +200.0% |
| Q3 2021 | $74,000 | -71.0% | 10,000 | 0.0% | 0.00% | -80.0% |
| Q2 2021 | $255,000 | +147.6% | 10,000 | 0.0% | 0.01% | +150.0% |
| Q1 2021 | $103,000 | +47.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | -14.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $82,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|